Rabah Iratni
Overview
Explore the profile of Rabah Iratni including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
68
Citations
1281
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Karam F, El Deghel Y, Iratni R, Dakroub A, Eid A
Cell Biochem Biophys
. 2025 Feb;
PMID: 39946032
Colorectal cancer (CRC) is the second leading cause of cancer-related mortality worldwide. While the incidence and mortality of CRC have decreased overall due to better screening, rates in adults under...
2.
El Mahi Y, Nizami Z, Wali A, Al Neyadi A, Magramane M, Al Azzani M, et al.
Front Pharmacol
. 2024 Aug;
15:1412565.
PMID: 39139643
Pancreatic cancer is a leading cause of cancer-related mortality worldwide with increasing global incidence. We previously reported the anticancer effect of ethanolic extract (RCE) in triple negative breast and colon...
3.
Al Azzani M, Nizami Z, Magramane R, Sekkal M, Eid A, Dhaheri Y, et al.
Phytother Res
. 2024 Jul;
38(9):4353-4385.
PMID: 38961675
Autophagy and endoplasmic reticulum (ER) stress are conserved processes that generally promote survival, but can induce cell death when physiological thresholds are crossed. The pro-survival aspects of these processes are...
4.
Alsamri H, Hasasna H, Dhaheri Y, Eid A, Attoub S, Iratni R
Front Oncol
. 2024 Mar;
13:1235201.
PMID: 38486934
[This corrects the article DOI: 10.3389/fonc.2019.00743.].
5.
Dakroub A, Dbouk A, Asfour A, Nasser S, El-Yazbi A, Sahebkar A, et al.
J Cell Physiol
. 2024 Feb;
239(5):e31212.
PMID: 38308646
C-peptide, a byproduct of insulin synthesis believed to be biologically inert, is emerging as a multifunctional molecule. C-peptide serves an anti-inflammatory and anti-atherogenic role in type 1 diabetes mellitus (T1DM)...
6.
Alsamri H, Dhaheri Y, Iratni R
Antioxidants (Basel)
. 2023 Jul;
12(7).
PMID: 37507889
Triple-negative breast cancer (TNBC), which lacks the expression of the three hormone receptors (i.e., estrogen receptor, progesterone receptor, and human epidermal growth factor receptor), is characterized by a high proliferative...
7.
Nizami Z, Aburawi H, Semlali A, Muhammad K, Iratni R
Antioxidants (Basel)
. 2023 Jun;
12(6).
PMID: 37371889
Reactive oxygen species (ROS) are metabolic byproducts that regulate various cellular processes. However, at high levels, ROS induce oxidative stress, which in turn can trigger cell death. Cancer cells alter...
8.
Alneyadi A, Nizami Z, Aburawi H, Hisaindee S, Nawaz M, Attoub S, et al.
Cancers (Basel)
. 2023 Jun;
15(10).
PMID: 37345018
Breast cancer continues to be the leading cause of cancer-related deaths among women worldwide. The most aggressive type of breast cancer is triple-negative breast cancer (TNBC). Indeed, not only does...
9.
Al Zein M, Boukhdoud M, Shammaa H, Mouslem H, El Ayoubi L, Iratni R, et al.
Drug Discov Today
. 2023 Jun;
28(9):103669.
PMID: 37328052
The tremendous success of immunotherapy in clinical trials has led to its establishment as a new pillar of cancer therapy. However, little clinical efficacy has been achieved in microsatellite stable...
10.
Rezaei S, Mahjoubin-Tehran M, Iratni R, Sahebkar A
Curr Med Chem
. 2023 May;
31(25):3954-3965.
PMID: 37151059
Prostate cancer is ranked second among the most common male cancers. Androgen deprivation therapy (ADT) has long been the first-line treatment and the basis for all other therapies, reducing circulating...